Search PubMed⌕ Search

PubMed · 7337421

[Hematologic changes in nutritional lead deficiency].

Abstract

In the present experiments hematological changes could be induced in growing rats by alimentary lead deficiency. The lead-depleted mothers of different generations had already shown a trend to lower values of hematocrit and mean corpuscular volume in comparison with control mothers. In young male rats of the F1-generation from lead-depleted mothers hematocrit was reduced by about 22%, hemoglobin by about 25%, the mean corpuscular volume by about 23%, and the mean corpuscular hemoglobin by about 28% as determined 3 days after weaning in comparison with control rats. Depletion of female rats till the 38th day of life intensified the hematological changes: hematocrit values were reduced by about 14%, hemoglobin by about 32%, the mean corpuscular volume by about 29%, mean corpuscular hemoglobin by about 37%, and the mean corpuscular hemoglobin concentration by about 12%. In the F2-generation rats of the depletion group always showed changed hematological values in comparison with control animals. Hematological changes normalized by repletion starting from the day of birth (crossing-over experiment) or the day of weaning (depletion-repletion experiment). In the crossing-over experiment, in which one half of the littermates of the lead-depleted mother and of a control mother were changed among one another on the day of birth, it could be shown that depletion during the fetal stage was decisive for development of hematological changes. Overall, the reproduced hematological changes resulting from lead depletion and their normalization after repletion are- besides the growth depression- a proof of the essentiality of lead.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A M Reichlmayr-Lais, M Kirchgessner. 1981. [Hematologic changes in nutritional lead deficiency].. https://doi.org/10.1159/000176507

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.

Thrombopoietin (TPO) is recognized as the primary regulator of megakaryocyte and platelet production. Two alternative hypotheses for the mechanism of regulation have been proposed: (1) platelet and/or megakaryocyte mass regulate circulating TPO levels by binding to TPO through TPO receptors (c-MPL), with subsequent internalization and degradation of the protein; (2) TPO mRNA produced by bone marrow (BM) stromal cells or BM cells modulates blood TPO levels or platelet counts. In myeloproliferative disorders (MPD), including primary myelofibrosis (MF) and essential thrombocythemia (ET), elevated blood TPO levels occur despite increased platelet and megakaryocyte mass. Therefore, in these diseases, elevated blood TPO levels cannot be explained by the first mechanism. The present study, was designed to measure TPO mRNA production by BM mononuclear cells and BM stromal cells using a relative RT-PCR technique, to verify the second mechanism. We found no increase of TPO mRNA production in either BM cells or in BM stromal cells in patients with MF and ET. Furthermore, in those patients with MF who had elevated plasma TPO levels, TPO mRNA levels in bone marrow fibroblasts (BMFs) or BM cells were not elevated as compared with controls. Therefore, we concluded that in patients with MF, the elevated plasma TPO levels are not due to enhanced production of TPO mRNA either by BMF, or BM cells. The TPO receptor (c-MPL) abnormalities including reduced MPL protein levels or defective TPO induced signal transduction pathways are the likely mechanisms.

Anemia, Hypochromic↗